Stocks With The Most
Fund Put Options
| Name | Net Calls | Puts | Calls |
Return since 30 Jun ‘17 |
|
|---|---|---|---|---|---|
| $2.77B | $4.44B | $1.68B | 29.2% |
|
|
| $2.14B | $3.8B | $1.65B | 6.35% |
|
|
| $829M | $1.22B | $395M | 92.9% |
|
|
4
State Street SPDR S&P Biotech ETF
XBI
$8.8B
| $602M | $1.43B | $826M | 77.3% |
|
| $365M | $606M | $241M | 67.9% |
|
|
| $270M | $1.45B | $1.18B | 27.7% |
|
|
| $233M | $474M | $241M | 37.2% |
|
|
| $232M | $409M | $177M | 69.3% |
|
|
| $222M | $304M | $82.1M | 21.8% |
|
|
| $213M | $473M | $261M | 117% |
|
|
11
iShares Biotechnology ETF
IBB
$8.56B
| $177M | $1.05B | $875M | 68.9% |
|
| $162M | $351M | $189M | 12.2% |
|
|
| $160M | $241M | $81.4M | 55.1% |
|
|
| $127M | $260M | $133M | 78.1% |
|
|
| $126M | $217M | $91M | 51.6% |
|
|
| $119M | $564M | $445M | 66.7% |
|
|
| $119M | $449M | $330M | 275% |
|
|
| $117M | $395M | $278M | 52.8% |
|
|
| $112M | $207M | $94.8M | 27% |
|
|
| $106M | $212M | $106M | 5.91% |
|
|
| $99M | $105M | $6.16M | 135% |
|
|
| $93.8M | $177M | $83.2M | 143% |
|
|
| $92.9M | $244M | $151M | 70.1% |
|
|
| $88.1M | $119M | $30.6M | 132% |
|
|
| $76.4M | $155M | $78.1M | 446% |
|